A study to assess real world efficacy of Anti PD-1 therapy in patients with non-small cell lung cancer
Latest Information Update: 15 Jul 2020
At a glance
- Drugs Nivolumab (Primary) ; Pembrolizumab (Primary)
- Indications Adenocarcinoma; Non-small cell lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- 15 Jul 2020 New trial record
- 12 Jun 2020 Results published in the Medicine